| Code | 9351B | ||||||||||
| MA number | 31/0257/16-S | ||||||||||
| Product Form: | tbl 14x10 mg (blis.PVC/Aclar/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 17.05.2016 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ezetimib Teva 10 mg_06.2021.pdf
|
| PIL: |
PIL_Ezetimib Teva 10 mg_12.2021.pdf
|
| Safety feature | Yes |
| Data update: | 07.10.2020 |
